AnaptysBio, Inc. - stock earnings
Stock symbol ANAB is outdated, potentially delisted? Maybe it is available on other exchange?
ANAB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -39.8 million USD | 3.5 million USD |
| 2022Q4 | -26.4 million USD | 6.8 million USD |
| 2022Q3 | -33.5 million USD | 1.3 million USD |
| 2022Q2 | -32.6 million USD | 1.2 million USD |
| 2022Q1 | -36.3 million USD | 970000 USD |
| 2021Q4 | -32.5 million USD | 1.0 million USD |
| 2021Q3 | -6.7 million USD | 20.9 million USD |
| 2021Q2 | -429000 USD | 30.0 million USD |
| 2021Q1 | -18.2 million USD | 11.2 million USD |
| 2020Q4 | 33.6 million USD | 60.0 million USD |
| 2020Q3 | -23.8 million USD | ? USD |
ANAB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -128.7 million USD | 10.3 million USD |
| 2021 | -57.8 million USD | 63.2 million USD |
| 2020 | -19.9 million USD | 75.0 million USD |
| 2019 | -97.3 million USD | 8.0 million USD |
| 2018 | -61.7 million USD | 5.0 million USD |
| 2017 | -30.1 million USD | 10.0 million USD |
ANAB
Price: $17.79
52 week price:
Earnings Per Share: -7.03 USD
P/E Ratio: 68.66
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 153225
Ebitda: -8.6 millionMarket Capitalization: 578.0 million